Hims & Hers Health News

Aktie
WKN:  A2QMYY ISIN:  US4330001060 US-Symbol:  HIMS Branche:  Pharmazeutika Land:  USA
28,15 $
+0,00 $
0,00%
24,088 € 00:30:00 Uhr
Depot/Watchlist
Marktkapitalisierung *
6,12 Mrd. €
Streubesitz
-
KGV
69,16
Nachhaltigkeits-Score
31 %
Index-Zuordnung
-
Weiter aufwärts? Long handeln - Jetzt mit Hebel 14,01: JE7QET
Werbung

Hims & Hers Health News

01.07.25 - PR Newswire
Berger Montague Investigates Securities Class Action Against Hims & Hers Health Inc. (NYSE: HIMS)
Berger Montague Investigates Securities Class Action Against Hims & Hers Health Inc. (NYSE: HIMS) PR Newswire
01.07.25 - PR Newswire
HIMS Investors with Losses in Excess of $100K Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit
HIMS Investors with Losses in Excess of $100K Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit PR Newswire
01.07.25 - PR Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 25, 2025 in Hims & Hers Health, Inc. Lawsuit - HIMS
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 25, 2025 in Hims & Hers Health, Inc. Lawsuit - HIMS PR Newswire
30.06.25 - PR Newswire
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm PR Newswire
30.06.25 - PR Newswire
HIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
HIMS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action ...
30.06.25 - PR Newswire
HIMS Investor Alert: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed
HIMS Investor Alert: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed PR Newswire
30.06.25 - PR Newswire
INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. (HIMS) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Hims & Hers Health, Inc. (HIMS) Investors with Substantial Losses Have Opportunity to Lead Class ...
27.06.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - HIMS ...
27.06.25 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Hims & Hers Health, Inc. - HIMS
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Hims & Hers Health, Inc. - HIMS PR Newswire
27.06.25 - PR Newswire
Hims & Hers Health, Inc. (HIMS) Faces Securities Class Actions After Novo Nordisk Cancels Partnership Over "Deceptive" Marketing of Wegovy®- Hagens Berman
Hims & Hers Health, Inc. (HIMS) Faces Securities Class Actions After Novo Nordisk Cancels Partnership Over "Deceptive" Marketing of Wegovy®- Hagens Berman PR Newswire
26.06.25 - PR Newswire
Faruqi & Faruqi Reminds Hims & Hers Health Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 25, 2025 - HIMS
Faruqi & Faruqi Reminds Hims & Hers Health Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 25, 2025 - HIMS PR Newswire
26.06.25 - PR Newswire
HIMS INVESTOR ALERT: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
HIMS INVESTOR ALERT: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit PR Newswire
26.06.25 - PR Newswire
HIMS Investors with Losses in Excess of $100K Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit
HIMS Investors with Losses in Excess of $100K Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit PR Newswire
25.06.25 - PR Newswire
Hims & Hers Health, Inc. (HIMS) Shares Crash After Novo Nordisk Cancels Partnership Over "Deceptive" Marketing of Wegovy, Faces Investor Scrutiny- Hagens Berman
Hims & Hers Health, Inc. (HIMS) Shares Crash After Novo Nordisk Cancels Partnership Over "Deceptive" Marketing of Wegovy, Faces Investor Scrutiny- Hagens Berman PR Newswire
24.06.25 - PR Newswire
Berger Montague Investigates Potential Securities Class Action Against Hims & Hers Health, Inc.
Berger Montague Investigates Potential Securities Class Action Against Hims & Hers Health, Inc. PR Newswire
23.06.25 - PR Newswire
Hims & Hers Health, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - HIMS
Hims & Hers Health, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - HIMS PR Newswire
23.06.25 - PR Newswire
HIMS INVESTIGATION ALERT: Investigation Launched into Hims & Hers Health, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm
HIMS INVESTIGATION ALERT: Investigation Launched into Hims & Hers Health, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm PR Newswire
23.06.25 wallstreetONLINE Redaktion
Kein Wegovy mehr: Novo Nordisk bricht Partnerschaft: Hims & Hers-Aktie fällt ins Bodenlose!
Novo Nordisk bricht mit Hims & Hers: Beide Aktien fallen drastisch, wobei der Telemedizinanbieter aus den USA den Kürzeren zieht.Tiefschlag für die Anteilsscheine von Hims & ...
07.06.25 wallstreetONLINE Redaktion
KI-Gesundheitsrevolution: Telemedizin: 7 profitable Aktien, die vom Zukunfts- & Wachstumsmarkt profitieren
Der Telemedizin-​Markt wächst rasant. Diese Unternehmen haben den Trend erkannt und erwirtschaften stetig steigende Gewinne.Ähnlich wie die gesetzliche Rente werden auch ...
03.06.25 wallstreetONLINE Redaktion
US-Telemedizin-Anbieter: Hims & Hers expandiert nach Europa: Zava bringt Millionen neue Nutzer!
Hims & Hers übernimmt die europäische Telemedizin-​Plattform Zava und wächst dadurch um 1,3 Millionen Nutzer. Die Aktie legt daraufhin im vorbörslichen Handel an der Nasdaq ...

Newssuche

Videos

newspaper
20.04.26 -2,08%
Technical Trading: GBP Long im Trend
GBP/USD Long Typ: Open End Turbo WKN: VV7A4S Hebel: 10 Laufzeit: OpenEnd Einstieg: Market ... Mehr »